Grammy Award-winning master trumpeter and composer Chris Botti will perform live Sunday, March 6, presented by the University of Alabama at Birmingham’s Alys Stephens Performing Arts Center.
Botti’s mesmerizing performances — with a stunning array of legends such as Sting, Barbra Streisand, Tony Bennett, Yo-Yo Ma, Frank Sinatra, Paul Simon, Vince Gill, Herbie Hancock, Mark Knopfler and Andrea Bocelli — have cemented his place as one of the most brilliant and inspiring forces of the contemporary music scene.
The performance will be at 7 p.m. in the Alys Stephens Center’s Jemison Concert Hall. Tickets are $48, $58 and $68. Call 205-975-2787 or visit AlysStephens.org.
He has amassed a spectacular variety of honors over two decades, including enough gold and platinum albums to become the nation’s largest-selling instrumental artist, according to his artist’s statement. Whether he is performing with illustrious symphonies or at renowned venues around the globe, his unparalleled crystalline and poetic sound transcends musical boundaries.
Since the release of his 2004 critically acclaimed CD “When I Fall in Love,” Botti’s success has crossed over to audiences usually reserved for pop music, and his ongoing association with PBS has led to four No. 1 jazz albums. Most recently, his latest album, “Impressions,” won the Grammy Award for Best Pop Instrumental Album. It is the latest in a stellar parade of albums, including “To Love Again: The Duets” (2005), “Italia (2007)” and the CD/DVD “Chris Botti in Boston” (2009). Performing worldwide and selling more than 4 million albums, he has found a form of creative expression that begins in jazz and expands beyond the limits of any single genre.
Event staff and attendees are required to wear masks indoors on campus regardless of vaccination status, as well as maintain proper distancing while on UAB’s campus, including at events.
Safety is UAB’s priority. The pandemic is a fluid situation that UAB is monitoring, in consultation with infectious disease and public health experts; events will be subject to change based on the latest COVID-19 safety guidelines.